SAGILITY LIMITED — Annual Report FY2026
Quality Scores
AI Summary
Sagility Limited (formerly Berkmeer India) has emerged as a specialized pure-play healthcare services provider focused exclusively on the U.S. payer and provider market. Incorporated in 2021, the company has rapidly scaled its operations, achieving a market share of 1.23% in the U.S. healthcare outsourcing sector by 2023. The financial trajectory shows robust growth with revenue jumping from INR 923 Cr to over INR 7,193 Cr in five years, supported by structural tailwinds in U.S. healthcare digitalization. Management has successfully transition the company from a private equity-held entity to…
Key Changes
The company has evolved from a private entity into a publicly listed specialized healthcare ITES provider focusing exclusively on the U.S. market. Strategic evolution is marked by the shift from basic claims processing to integrated healthcare-focused technology-enabled solutions for both payers and providers. The June 2026 acquisition of CareSeed demonstrates a commitment to moving up the value chain into specialized healthcare segments. Digital transformation initiatives are evident in the steady improvement of operating margins from 21% in 2022 to a projected 24% by 2026. The business is successfully leveraging its offshore delivery sites to service high-cost U.S. healthcare administrative needs. Geographic concentration remains North America, which is a deliberate strategic choice to…
Management Commentary
The management team has demonstrated high execution capability by navigating a complex transition from a newly incorporated entity to a listed mid-cap leader. Strategic clarity is evident in their exclusive focus on the U.S. healthcare niche, avoiding the distraction of multi-sector diversification. The board has maintained transparency through frequent investor communications and detailed quarterly presentations. Incentive alignment is being formalized through the 'ESOP/PSU Scheme 2026', which explicitly links rewards to financial performance and 70% financial criteria. While the promoter holding has seen a significant planned dilution (from 82% to 50%) via the IPO process, it has attracted high-quality institutional interest. The leadership's decision to clarify ESOP terms before…
Financial Highlights
The company exhibits strong growth momentum with a 3-year compounded sales growth of 19% and profit growth of 86%. Operating profit margins (OPM) have shown remarkable resilience, maintaining a steady channel between 21% and 25% despite varying macroeconomic conditions. Profit before tax (PBT) turned from a nominal loss in FY22 to INR 1,239 Cr by FY26, indicating significant operational leverage. The return on equity (ROE) is on an improving trend, moving from low single digits to 11%, though it remains below elite IT benchmarks. Debt reduction is a visible theme, with borrowings falling from INR 4,788 Cr to INR 1,111 Cr. The earnings quality is high, with reported PAT closely tracking operating cash flows.
Major Opportunities
- Robust Revenue CAGR of 19% over 3 years
- Significant net debt reduction from 4788Cr to 1111Cr
- Strong CFO/OP ratio consistently near or above 90%
Major Risks
- High geographic concentration (100% U.S. revenue)
- High client concentration (Top 10 clients account for major share)
- Promoter holding reduced significantly from 82% to 51%
Unlock the full report
Unlock complete company intelligence with 20+ analysis sections, visual insights, AI chat, rankings, and downloadable PDF reports.